Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-02-20 | 2026-02-20 |
| Drug Identification Number | 01935941 | 01935941 |
| Brand name | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML |
| Common or Proper name | Heparin Sodium in Dextrose | Heparin Sodium in Dextrose |
| Company Name | B. BRAUN MEDICAL INC | B. BRAUN MEDICAL INC |
| Ingredients | HEPARIN SODIUM SODIUM PHOSPHATE DIBASIC CITRIC ACID DEXTROSE | HEPARIN SODIUM SODIUM PHOSPHATE DIBASIC CITRIC ACID DEXTROSE |
| Strength(s) | 5000UNIT 410MG 93MG 5G | 5000UNIT 410MG 93MG 5G |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500mL | 500mL |
| Additional packaging sizes | ||
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-02-27 | 2026-02-27 |
| Actual start date | ||
| Estimated end date | 2026-04-01 | 2026-04-01 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |